ABT logo Abbott Laboratories +
Abbott Laboratories
+

Abbott Laboratories (ABT) Business News

Track Abbott Laboratories in real time with a live news feed covering Abbott Laboratories stock news, official press releases, company announcements, and an archive of historical Abbott Laboratories news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

ABT DCF Analysis: Intrinsic Value $94 vs Price $111

GuruFocus

7:25 AM | Monday | Aug 17, 2026

news photo
Loading...

On August 17, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company currently facing some price performance challenges. The stock has sh

Read full article redirect
7:25 AM | Monday | Aug 17, 2026

ABT DCF Analysis: Intrinsic Value $94 vs Price $111

GuruFocus

On August 17, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company currently facing some price performance challenges. The stock has sh

Read full article arrow
News Thumbnail
5:56 AM | Monday | Aug 17, 2026

Fifth Third Wealth Advisors LLC Decreases Stock Holdings in Abbott Laboratories $ABT

Defense World

Fifth Third Wealth Advisors LLC reduced its holdings in shares of Abbott Laboratories (NYSE: ABT) by 32.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 30,646 shares of the healthcare product maker's stock after selling 14,830 shares during the quarter.

Read full article arrow
News Thumbnail
5:56 AM | Monday | Aug 17, 2026

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Sells 20,339 Shares of Abbott Laboratories $ABT

Defense World

Commonwealth of Pennsylvania Public School Empls Retrmt SYS lessened its stake in Abbott Laboratories (NYSE: ABT) by 5.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 384,719 shares of the healthcare product maker's stock after selling 20,339 shares

Read full article arrow
News Thumbnail
5:56 AM | Monday | Aug 17, 2026

Abbott Laboratories $ABT Shares Bought by Crossmark Global Holdings Inc.

Defense World

Crossmark Global Holdings Inc. raised its stake in Abbott Laboratories (NYSE: ABT) by 2.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 321,847 shares of the healthcare product maker's stock after purchasing an additional 8,763 shares during the quarter. Crossmark Global Holdings

Read full article arrow
News Thumbnail
8:10 AM | Saturday | Aug 15, 2026

How To Invest $100,000 In A Retiree's SWAN Income Portfolio

Seeking Alpha

The bull market that started in 2022 still continues, making the market somewhat overvalued, and we recommend proven strategies over investing in what is popular. A SWAN (Sleep Well At Night) income portfolio aims for consistent income, growth, and lower volatility through diversification and strategic planning, especially suited for income investors and retirees. We provide a framework for a long-term portfolio with multiple buckets that is flexible to suit individual needs, limitations, and preferences.

Read full article arrow
News Thumbnail
9:51 AM | Thursday | Aug 13, 2026

What's Backing Abbott's Established Pharmaceuticals Division Growth

Zacks Investment Research

ABT's EPD growth is fueled by emerging-market strength, broad branded generics and healthcare demand, with biosimilars adding opportunities.

Read full article arrow
News Thumbnail
7:53 AM | Thursday | Aug 13, 2026

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

247 Wallst

Wall Street analysts made bold moves Thursday, slashing targets on some names while dramatically upgrading others, and the gap between winners and losers tells a story about where smart money is quietly repositioning ahead of the next market move.

Read full article arrow
News Thumbnail
9:14 AM | Wednesday | Aug 12, 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

PRNewsWire

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national blood crisis after donations dropped to a four-year summer low, threatening the availability of lifesaving blood for patients across the country Abbott and the Big Ten urge people to donate blood now and will count those early donations toward the competition, which officially kicks off Aug. 26 Anyone can donate blood anywhere in the U.S. between Aug. 12-Dec.
4 and log their donation starting Aug. 26 for a Big Ten school at BigTen.org/Abbott or by texting GIVEBLOOD to 222688 (ABBOTT) and select an exclusive, limited-edition T-shirt* while supplies... Read more

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Aug 11, 2026

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

PRNewsWire

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future Lingo product features Lingo, Abbott's over-the-counter continuous glucose monitor (CGM), helps people understand the impact of nutrition, activity, sleep and stress on their glucose so they can make meaningful lifestyle changes ABBOTT PARK, Ill., Aug. 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a first-of-its-kind partnership with Google Health to redefine how people understand and manage their health.

Read full article arrow
News Thumbnail
11:45 AM | Monday | Aug 10, 2026

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?

Zacks Investment Research

Abbott's Medical Devices growth, EPD momentum and improving Nutrition support its outlook, but China risks, costs and valuation warrant caution.

Read full article arrow
News Thumbnail